title: mTORC2 dictates Warburg effect and drug resistance.
authors.affiliation: Ludwig Institute for Cancer Research; University of California, San Diego; La Jolla, CA USA.
authors.forename: Kenta
authors.initials: K
authors.lastname: Masui
authors.affiliation: Ludwig Institute for Cancer Research; University of California, San Diego; La Jolla, CA USA; Moores Cancer Center; University of California, San Diego; La Jolla, CA USA.
authors.forename: Webster K
authors.initials: WK
authors.lastname: Cavenee
authors.affiliation: Ludwig Institute for Cancer Research; University of California, San Diego; La Jolla, CA USA; Moores Cancer Center; University of California, San Diego; La Jolla, CA USA; Department of Pathology; University of California, San Diego; La Jolla, CA USA.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Mischel
mesh_terms: D000818:Animals; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism*; D006019:Glycolysis; D006801:Humans; D046912:Multiprotein Complexes / Q000378:metabolism*; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D051858:Forkhead Transcription Factors; D046912:Multiprotein Complexes; D016271:Proto-Oncogene Proteins c-myc; D058570:TOR Serine-Threonine Kinases
keywords: FoxO; acetylation; c-Myc; drug resistance; glioblastoma; mTORC2; metabolic reprogramming